ZA93955B - Liposomal itraconazole formulations - Google Patents

Liposomal itraconazole formulations

Info

Publication number
ZA93955B
ZA93955B ZA93955A ZA93955A ZA93955B ZA 93955 B ZA93955 B ZA 93955B ZA 93955 A ZA93955 A ZA 93955A ZA 93955 A ZA93955 A ZA 93955A ZA 93955 B ZA93955 B ZA 93955B
Authority
ZA
South Africa
Prior art keywords
liposomal
itraconazole
itraconazole formulations
phospholipid
formulations
Prior art date
Application number
ZA93955A
Other languages
English (en)
Inventor
Giovanni Lucchetti
Giuseppe Assogna
Pietro Bagnato
Original Assignee
Janssen Farmaceutici Spa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Janssen Farmaceutici Spa filed Critical Janssen Farmaceutici Spa
Publication of ZA93955B publication Critical patent/ZA93955B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Liposomes
    • A61K9/1277—Processes for preparing; Proliposomes

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Dispersion Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
ZA93955A 1992-02-12 1993-02-11 Liposomal itraconazole formulations ZA93955B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92200397 1992-02-12

Publications (1)

Publication Number Publication Date
ZA93955B true ZA93955B (en) 1994-08-11

Family

ID=8210419

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA93955A ZA93955B (en) 1992-02-12 1993-02-11 Liposomal itraconazole formulations

Country Status (17)

Country Link
EP (1) EP0625899B1 (xx)
JP (1) JPH07503953A (xx)
KR (1) KR940703651A (xx)
CN (1) CN1076614A (xx)
AT (1) ATE138561T1 (xx)
AU (1) AU661754B2 (xx)
CA (1) CA2129828A1 (xx)
DE (1) DE69302897T2 (xx)
DK (1) DK0625899T3 (xx)
ES (1) ES2091019T3 (xx)
GR (1) GR3020695T3 (xx)
IL (1) IL104689A (xx)
MX (1) MX9300708A (xx)
MY (1) MY131524A (xx)
TW (1) TW267103B (xx)
WO (1) WO1993015719A1 (xx)
ZA (1) ZA93955B (xx)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW438601B (en) * 1994-05-18 2001-06-07 Janssen Pharmaceutica Nv New mucoadhesive emulsion compositions and a process for the preparation thereof
WO1999033467A1 (en) 1997-12-31 1999-07-08 Choongwae Pharma Corporation Method and composition of an oral preparation of itraconazole
DE60023465T2 (de) 1999-03-24 2006-07-20 R.P. Scherer Technologies, Inc., Las Vegas Pharmazeutische formulierungen mit verbesserter löslichkeit in wasser
KR100331529B1 (ko) * 1999-06-16 2002-04-06 민경윤 난용성 항진균제의 경구투여용 조성물 및 그의 제조 방법
KR100388605B1 (ko) * 2000-06-13 2003-06-25 코오롱제약주식회사 용해도 및 용해속도가 향상된 이트라코나졸의 액상 조성물 및 이를 이용한 이트라코나졸 제제와 그 제조방법
GB0015239D0 (en) * 2000-06-21 2000-08-16 Biochemie Gmbh Organic compounds
CU23175A1 (es) * 2000-07-17 2006-09-22 Ct De Investigacion Y Desarrol Formulacion liposomica de propionato de clobetasol
WO2004108114A2 (en) * 2003-03-31 2004-12-16 Dinesh Shantilal Patel Anti-fungal composition and a process for its manufacture
KR100712734B1 (ko) 2005-05-31 2007-05-04 에이엔에이치 케어연구소(주) 이트라코나졸을 함유하는 피부외용제
KR100970911B1 (ko) * 2007-12-13 2010-07-20 재단법인서울대학교산학협력재단 트리아졸계 항진균제를 함유하는 반고형 외용제 및 이의 제조방법
US20090175810A1 (en) 2008-01-03 2009-07-09 Gareth Winckle Compositions and methods for treating diseases of the nail
JP2011508780A (ja) * 2008-01-04 2011-03-17 ケラー，ブライアン，チャールズ 抗真菌薬の増強された送達
US8039494B1 (en) 2010-07-08 2011-10-18 Dow Pharmaceutical Sciences, Inc. Compositions and methods for treating diseases of the nail
SG11201602596UA (en) 2013-10-03 2016-04-28 Dow Pharmaceutical Sciences Stabilized efinaconazole compositions
EP3071295A4 (en) * 2013-11-22 2017-05-31 Dow Pharmaceutical Sciences, Inc. Anti-infective methods, compositions, and devices
WO2019040363A1 (en) * 2017-08-20 2019-02-28 University Of Connecticut AZOLE-TYPE COMPOUND ANALOGUES AND METHODS OF USE

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3532562A1 (de) * 1985-09-12 1987-03-12 Dolorgiet Gmbh & Co Kg Transdermal resorbierbare, wasserhaltige zubereitungen von arylpropionsaeurederivaten und verfahren zur herstellung derselben
DE3600947A1 (de) * 1986-01-15 1987-07-16 Kali Chemie Pharma Gmbh Antimykotische emulsionen
AU598002B2 (en) * 1986-07-15 1990-06-14 Cilag Ltd. Method of preparing single bilayered liposomes
US4783450A (en) * 1987-04-13 1988-11-08 Warner-Lambert Company Use of commercial lecithin as skin penetration enhancer
EP0382777B1 (en) * 1987-10-19 1994-10-12 The Liposome Company, Inc. Aqueous preparation of liposome composition
US5169846A (en) * 1989-10-12 1992-12-08 Crooks Michael J Non-aqueous micellar solutions of anthelmintic benzimidazoles, closantel, or phenothiazine, and insect growth regulators

Also Published As

Publication number Publication date
ATE138561T1 (de) 1996-06-15
AU3453593A (en) 1993-09-03
DE69302897T2 (de) 1996-09-26
EP0625899A1 (en) 1994-11-30
MX9300708A (es) 1994-07-29
GR3020695T3 (en) 1996-10-31
ES2091019T3 (es) 1996-10-16
EP0625899B1 (en) 1996-05-29
KR940703651A (ko) 1994-12-12
WO1993015719A1 (en) 1993-08-19
CA2129828A1 (en) 1993-08-19
JPH07503953A (ja) 1995-04-27
AU661754B2 (en) 1995-08-03
DK0625899T3 (da) 1996-06-17
CN1076614A (zh) 1993-09-29
DE69302897D1 (de) 1996-07-04
IL104689A0 (en) 1993-06-10
IL104689A (en) 1996-12-05
TW267103B (xx) 1996-01-01
MY131524A (en) 2007-08-30

Similar Documents

Publication Publication Date Title
IL104689A0 (en) Liposomal formulations comprising itraconazole
CA2182200A1 (en) Formulations for Factor IX
HUT62201A (en) Method for producing galen preparations containing cyclosporines as active ingredient
AU639975B2 (en) Topical preparations for treating human nails
CA2169071A1 (en) Methods for modulating the human sexual response
CA2175472A1 (en) Propylene glycol stearate vesicles
AU3406997A (en) Topical product formulations containing strontium for reducing skin irritation
GR3023825T3 (en) Benzopyran derivatives, processes for their preparation and their use and preparations containing the compounds
CA2099188A1 (en) Use of a cosmetic composition
MY104412A (en) Acne treatment.
EP0831780A4 (en) IMPROVED LIPSOMAL FORMULATION
ZA93954B (en) Liposomal piroxicam formulations
FR2687913B1 (xx)
CA2026763A1 (fr) Composition cosmetique ou pharmaceutique pour application topique contenant au moins un derive retinoide et au moins un derive de pyrimidine, son utilisation comme medicament et procede de traitement correspondant
ZA972180B (en) Topical formulations for the treatment of psoriasis of the nail.
GB2255780B (en) The use of oligourethanes as forming agents for aqueous pigment preparations
IT1255762B (it) Formulazioni liposomiche di piroxicam.
AU5609386A (en) Topical agents for inhibiting the melanin generation
AU4956193A (en) Stable, highly concentrated formulations of fluorescein derivatives
KR950700743A (ko) 프로스타사이클린류를 활성성분으로서 함유하는 외용 피부치료제 조성물(dermatologic preparation composition containing prostacyclin as active ingredient)
AU5259486A (en) Arylalkoxyphenyl-allylic alcohols as agents for the treatment of hypersensitive ailments
WO1994003148A3 (de) Hautbräunungsmittel
AU4629989A (en) Anti-inflammatory active ingredients for cosmetic preparations
AU6271490A (en) Anti-inflammatory active ingredients for cosmetic preparations
PT82421B (en) Process for the preparation of topical agents for inhibiting the melanin generation